Made available in DSpace on 2018-12-11T17:30:49Z (GMT). No. of bitstreams: 0 Previous issue date: 2017-01-01; Royal Society of Chemistry; The neuroleptic drug thioridazine has been recently repositioned as possible anti-tubercular drug. Thioridazine showed anti-tubercular activity against drug resistant mycobacteria but it is endowed with adverse side effects. A small library of thioridazine derivatives has bee...